Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort descending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort descending Site Location Division Business Functional Area Date Posted
Business Data Migration Expert – Supply chain Hyderabad (Office) India Operations CTS BD&L & Strategic Planning Sep 19, 2024
Business Data Migration Expert (Finance) Prague Czech Republic Operations CTS BD&L & Strategic Planning Jun 19, 2024
Business Data Migration Expert (Temporary 18 months) INSURGENTES Mexico Operations CTS BD&L & Strategic Planning Sep 03, 2024
Business Data Migration Lead INSURGENTES Mexico Operations CTS BD&L & Strategic Planning Oct 23, 2024
Business Excellence & Execution IM Head, Mexico INSURGENTES Mexico International Innovative Medicines Marketing Oct 21, 2024
Business Planning Analysis Manager / Analyst INSURGENTES Mexico Biomedical Research CTS Audit & Finance Oct 23, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024
Business process expert - Life Sciences(Regulatory, CSR, PV) Hyderabad (Office) India Operations CTS Technology Transformation Sep 09, 2024
Buyer Indianapolis USA Operations Innovative Medicines Procurement Oct 21, 2024
Buyer - Corporate Spend Prague Czech Republic Operations CTS Procurement Oct 18, 2024
Buyer - Marketing Prague Czech Republic Operations CTS Procurement Oct 18, 2024
Buyer (with Italian) Prague Czech Republic Operations CTS Procurement Oct 24, 2024
Buyer Indirect Procurement TechOps Prague Czech Republic Operations Innovative Medicines Procurement Jul 19, 2024
Buyer LACan (Temporary) INSURGENTES Mexico Operations CTS Procurement Sep 15, 2024
Buyer with German Prague Czech Republic Operations CTS Procurement Aug 23, 2024
Buyer with Italian Prague Czech Republic Operations Innovative Medicines Procurement Sep 15, 2024
C&Q Engineer - Senior Executive Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jul 23, 2024
Capability Building Manager Milano Italy International Innovative Medicines Sales Oct 22, 2024
Cardiologist Physician Scientist (Associate Director/Director) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 05, 2024
Cardiovascular Institutional Sales Specialist– Boston – Remote Field Sales (USA) USA US Innovative Medicines Sales Sep 17, 2024
Cardiovascular Territory Account Specialist (Part-Time) – Bakersfield, CA – Remote Field Sales (USA) USA US Innovative Medicines Sales Oct 04, 2024
Cardiovascular Therapeutic Area Head Warsaw Poland International Innovative Medicines Commercial & General Management Oct 23, 2024
CDD Développeur/Ingénieur Data H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Marketing Jun 27, 2024
Cell and Gene Warehouse Specialist East Hanover USA Development Innovative Medicines Technical Operations Jul 12, 2024
Cell Processing Specialist I, AM Shift Morris Plains USA Operations Innovative Medicines Technical Operations Oct 18, 2024
Cell Processing Specialist I, PM Shift Morris Plains USA Operations Innovative Medicines Technical Operations Oct 18, 2024
Center Operation Manager Chengdu (Sichuan Province) China International Innovative Medicines Marketing Sep 03, 2024
Center Operation Manager Shanghai (Shanghai) China International Innovative Medicines Marketing Sep 03, 2024
Center Operation Manager Beijing (Beijing) China International Innovative Medicines Marketing Sep 03, 2024
Central Integrated Scientific Review Committee Lead Dublin (Novartis Corporate Center (NOCC)) Ireland Development Innovative Medicines Research & Development Oct 14, 2024
Change Control Coordinator Hyderabad (Office) India Operations Innovative Medicines Technical Operations Jun 03, 2024
Chef commercial BPA Montreal Canada International Innovative Medicines Audit & Finance Oct 08, 2024
Chef de produit rhumatologie H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Marketing Oct 25, 2024
Chef de Produit Snr en Dermatologie H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Marketing Oct 25, 2024
Chef de Projet Ingénierie (h/f) Huningue France Operations Innovative Medicines Technical Operations Oct 15, 2024
Chef de Projet Omnicanal – Apprenti H/F Paris Headquarter (Novartis Pharma S.A.S.) France International Innovative Medicines Others Jul 04, 2024
Chef de projets cliniques Montreal Canada International Innovative Medicines Research & Development Oct 26, 2024
Chef principal, Planification de nouveaux produits Montreal Canada International Innovative Medicines Market Access Oct 21, 2024
Chef, Communications corporatives Montreal Canada Corporate Affairs CTS Communications & Public Affairs Oct 21, 2024
Chef, Éducation médicale - Cancer du sein Montreal Canada International Innovative Medicines Research & Development Oct 18, 2024
Chemical Expert Fire Brigade Kundl Austria Operations Innovative Medicines Facilities & Administration Oct 24, 2024
Civil Architectural Structural - Executive Hyderabad (Office) India Operations Innovative Medicines Technical Operations Oct 09, 2024
Clinical Biospecimen Senior Scientist Head Office (Japan) (Pharmaceuticals) Japan Development Innovative Medicines Research & Development Sep 03, 2024
Clinical Data Specialist Hyderabad (Office) India Biomedical Research Pharma Research Research & Development May 07, 2024
Clinical Data Specialist I Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Clinical Data Specialist II Hyderabad (Office) India Biomedical Research Research & Development Jul 10, 2024
Clinical Development Functional Head London (The Westworks) United Kingdom Development Innovative Medicines Research & Development Sep 03, 2024
Clinical Development Medical Director East Hanover USA Development Innovative Medicines Research & Development Apr 24, 2024
Clinical Development Medical Director Basel (City) Switzerland Development Innovative Medicines Research & Development Sep 30, 2024
Clinical Development Medical Director - Cardio-Renal-Metabolism East Hanover USA Development Innovative Medicines Research & Development Sep 26, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only